Tirzepatide
Anti-diabetic and weight loss medication
Tirzepatide ▸ Facts ▸ Comments ▸ News ▸ Videos
Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. It is sold under the brand name Mounjaro for diabetes treatment, and Zepbound for weight loss and treatment of obstructive sleep apnea.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Weight loss drug gets US nod to treat sleep apnea; India launch likely next yearThe US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals...IndiaTimes - Published |
| Search this site and the web: |
